Healius Ltd (ASX:HLS) insider Robert Hubbard purchased 25,000 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were purchased at an average price of A$3.09 ($2.19) per share, with a total value of A$77,150.00 ($54,716.31).
The business’s 50-day moving average price is A$2.95 and its 200 day moving average price is A$2.95. The firm has a market cap of $1.93 billion and a P/E ratio of 620.00. The company has a debt-to-equity ratio of 39.90, a current ratio of 0.88 and a quick ratio of 0.78. Healius Ltd has a 1-year low of A$2.19 ($1.55) and a 1-year high of A$3.32 ($2.35).
The company also recently declared a Final dividend, which will be paid on Friday, September 27th. Stockholders of record on Friday, September 27th will be issued a dividend of $0.034 per share. The ex-dividend date of this dividend is Thursday, August 29th. This represents a dividend yield of 1.13%. Healius’s dividend payout ratio is currently 86.96%.
Healius Limited provides various services and facilities to general practitioners, dentists, physiotherapists, specialists, and other healthcare professionals in Australia. It operates through three segments: Pathology, Medical Centres, and Imaging. The company offers diagnostic imaging services, such as X-ray, ultrasound, computerized tomography, mammography, MRI, positron emission tomography, interventional radiology, and nuclear medicine services; and medical laboratory and pathology services.
Further Reading: How Do Front-End Loads Impact an Investment?
Receive News & Ratings for Healius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healius and related companies with MarketBeat.com's FREE daily email newsletter.